Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1991-11-27
1993-11-30
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424469, 424470, 424486, 424487, 424488, 424494, 424496, 424497, 424498, 424501, 424502, 424495, A61K 922, A61K 926
Patent
active
052663310
ABSTRACT:
A solid controlled release, oral dosage form, the dosage form comprising a therapeutically effective amount of oxycodone or a salt thereof in a matrix wherein the dissolution rate in vitro of the dosage form, when measured by the USP Paddle Method of 100 rpm in 900 ml aqueous buffer (pH between 1.6 and 7.2) at 37.degree. C. is between 12.5% and 42.5% (by weight) oxycodone released after 1 hour, between 25% and 55% (by weight) oxycodone released after 2 hours, between 45% and 75% (by weight) oxycodone released after 4 hours and between 55% and 85% (by weight) oxycodone released after 6 hours, the in vitro release rate being independent of pH between pH 1.6 and 7.2 and chosen such that the peak plasma level of oxycodone obtained in vivo occurs between 2 and 4 hours after administration of the dosage form.
REFERENCES:
patent: 4861598 (1989-08-01), Oshlack
patent: 4990341 (1991-02-01), Goldie et al.
Chasin Mark
Minogue John J.
Oshlack Benjamin
Euroceltique S.A.
Page Thurman K.
Spear James M.
LandOfFree
Controlled release oxycodone compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release oxycodone compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release oxycodone compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2093898